A Novel Approach to Applying Genomic Patient Data to Improve Multiple Sclerosis Treatments, New Webinar Hosted by Xtalks

Share Article

MS is difficult to diagnose and manage due to a lack of identified biomarkers that predict disease onset, progression and response to therapy. To make precision medicine for MS a reality and to help improve care for people with the disease, scientists need access to high-quality, deeply-annotated clinical genomic datasets generated in a real-world patient care setting. In this webinar, learn about a new study designed to assess EHR data, patient-reported outcomes, imaging data and blood samples in a quick, secure and economical manner.

Xtalks Life Science Webinars

To make precision medicine for MS a reality, scientists need access to high-quality, deeply-annotated clinical genomic datasets generated in a real-world patient care setting.

There are over 2.3 million people with multiple sclerosis (MS) worldwide; in the US alone, more than 450,000 people are living with MS today and 10,000 new cases are diagnosed each year. The need for precision medicine-based approaches to diagnose and treat MS is more critical today than ever.

MS is difficult to diagnose and manage due to a lack of identified biomarkers that predict disease onset, progression and response to therapy. To make precision medicine for MS a reality, scientists need access to high-quality, deeply-annotated clinical genomic datasets generated in a real-world patient care setting.

Join Megan Laurance, PhD, Senior Director of Data Services at DNAnexus and Greg Tranah, PhD, Director of the Center for Precision Medicine at Sutter Health in a live webinar on Monday, June 10, 2019 at 1pm EDT to learn about a new study designed to assess EHR data, patient-reported outcomes, imaging data and blood samples in a quick, secure and economical manner. The speakers will discuss the following features of the first large-scale clinical genomic MS study:

  • Study components
  • A technology platform capable of assessing clinical and genomic features of MS
  • Strategies for tracking MS subtypes, disability progression and differential response to therapy
  • Potential implications for improved diagnosis and treatment

This webinar will appeal to broad audiences including clinician researchers, biomarker sciences directors, VPs of precision medicine initiatives and health/medical media.
For more information or to register for this event, visit A Novel Approach to Applying Genomic Patient Data to Improve Multiple Sclerosis Treatments.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Candice Tang
Visit website